CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Oculus GO VR HMD, application Happy Place (© Mimerse) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03762213
NCT03762213N/ACompleted
CompareCT.gov

Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome: A Pilot Randomized Controlled Trial

Tufts Medical Center·interventional·Posted Dec 3, 2018·Updated Jan 26, 2021

In Brief

A clinical study evaluating Oculus GO VR HMD, application Happy Place (© Mimerse) and iPad, application Happy Place (© Mimerse) for Amplified Musculoskeletal Pain Syndrome and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

A pilot randomized controlled trial to assess feasibility, acceptability and generate outcome domains for a future RCT testing the efficacy of immersive virtual reality on pain intensity in pediatric amplified musculoskeletal pain syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmplified Musculoskeletal Pain Syndrome, Reflex Sympathetic Dystrophy, Complex Regional Pain Syndromes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 3, 2018
Enrollment StartDec 20, 2018
Primary CompletionAug 29, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.6 years ago

Interventions

Oculus GO VR HMD, application Happy Place (© Mimerse)device

The Entertainment Software Rating Board (ESRB) has rated Happy Place as 'E' ('Everyone' or content suitable for all ages).

iPad, application Happy Place (© Mimerse)device

The Entertainment Software Rating Board (ESRB) has rated Happy Place as 'E' ('Everyone' or content suitable for all ages).